Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients.

Saffarian, Zahra; Samii, Rana; Hadizadeh, Alireza; Ghanadan, Alireza; Vahidnezhad, Hassan

Saffarian, Zahra; Samii, Rana; Hadizadeh, Alireza; Ghanadan, Alireza; Vahidnezhad, Hassan.

Afiliação

Saffarian Z; Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran.
Samii R; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hadizadeh A; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ghanadan A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Vahidnezhad H; Department of Pathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Dermatol Ther ; 35(11): e15898, 2022 11.

Article em En | MEDLINE | ID: mdl-36196579

Assuntos

COVID-19; Transtornos da Pigmentação; Púrpura; Doenças Vasculares; Humanos; SARS-CoV-2; Vacinas contra COVID-19/efeitos adversos; COVID-19/prevenção & controle; Púrpura/diagnóstico; Púrpura/etiologia; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Pigmentação / Púrpura / Doenças Vasculares / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google